Clinical Trial Update: Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rectal artery infusion chemotherapy in combination with an anti-PD1 antibody for rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Neoplasms

Drugs mentioned

• Anti-PD1 antibody
• rectal artery infusion chemotherapy

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Rectal Neoplasms | Phase 2 | Status: UNKNOWN